PedAM
Pediatric Disease Annotations & Medicines
| Disease | portal hypertension |
| Phenotype | |cirrhosis |
| Sentences | 166 |
| PubMedID- 21423905 | Color doppler evaluation of left gastric vein hemodynamics in cirrhosis with portal hypertension and its correlation with esophageal varices and variceal bleed. |
| PubMedID- 23831908 | The natural history of cirrhotic patients is highly variable due to several factors including hepatic synthetic function, presence and degree of portal hypertension, the cause of cirrhosis, the possibility of resolution of the underlying damaging process, and the occurrence of liver cancer. |
| PubMedID- 26530427 | Moderate and severe liver diseases were cirrhosis combined with portal hypertension without and with history of varices bleeding [14]. |
| PubMedID- 24099470 | Background: the hepatic venous pressure gradient (hvpg) is an invasive, but important diagnostic and prognostic marker in cirrhosis with portal hypertension (pht). |
| PubMedID- 21606920 | The experimental study of liver cirrhosis with portal hypertension syndrome, modeled in 38 dogs, has been performed. |
| PubMedID- 21501480 | The obstruction of bile flow results in worsening cholestasis, liver fibrosis, and cirrhosis, which lead to portal hypertension and a decline in hepatic synthetic function. |
| PubMedID- 21705304 | A detailed interview and examination by occupational health and other medical specialists revealed that the patient had been suffering from wilson's disease from the age of 13, and had now developed hepatic manifestations (compensated liver cirrhosis with portal hypertension), neurological manifestations (dystonia, dysarthria, muscle weakness, vertigo), and psychiatric manifestations (depression, insomnia, cognitive impairment) of the disease, including problems partially caused by long-lasting treatment with copper chelating agents (neurological and haematological manifestations). |
| PubMedID- 26302944 | Additionally, portal hypertensive enteropathy (phe) associated with portal hypertension in patients with liver cirrhosis has been reported to be a major cause of gastrointestinal bleeding [16]. |
| PubMedID- 23606973 | Variceal hemorrhage is perhaps the most devastating portal hypertension-related complication in patients with cirrhosis, occurring in up to 30% of such individuals during the course of their illness. |
| PubMedID- 22441510 | Conclusion: hscrp is elevated in patients with cirrhosis and is associated with portal hypertension and decreased survival. |
| PubMedID- 24940392 | In addition, cirrhosis leads to portal hypertension and hyperdynamic circulation that can have widespread effects in the body (15). |
| PubMedID- 25834800 | If liver fibrosis progress to cirrhosis, complications arising from portal hypertension and functional hepatocyte loss develop. |
| PubMedID- 22334252 | Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta-blockers. |
| PubMedID- 25356325 | Resultant complications included compensated cirrhosis with portal hypertension, oesophageal varices and a previous episode of culture-negative sbp. |
| PubMedID- 21785606 | Intestinal bacterial overgrowth, seen in patients with advanced cirrhosis as a result of portal hypertension, has been noted to be a prerequisite for the facilitation of bacterial translocation. |
| PubMedID- 25912838 | However, it is not clear to what extent the progression of hepatitis c is modified once patients develop cirrhosis with severe portal hypertension (csph) (hvpg >/= 10 mm hg). |